133 related articles for article (PubMed ID: 38282294)
1. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
[TBL] [Abstract][Full Text] [Related]
2. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
3. First evidence of genotype-phenotype correlations in Gorlin syndrome.
Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
5. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
6. SUFU-associated Gorlin syndrome: Expanding the spectrum between classic nevoid basal cell carcinoma syndrome and multiple hereditary infundibulocystic basal cell carcinoma.
Álvarez-Salafranca M; García-García M; Montes-Torres A; Rivera-Fuertes I; López-Giménez MT; Ara M
Australas J Dermatol; 2023 May; 64(2):249-254. PubMed ID: 36825822
[TBL] [Abstract][Full Text] [Related]
7. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.
Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J
J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808
[TBL] [Abstract][Full Text] [Related]
8. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
[TBL] [Abstract][Full Text] [Related]
10. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract][Full Text] [Related]
11. Identification of a SUFU germline mutation in a family with Gorlin syndrome.
Pastorino L; Ghiorzo P; Nasti S; Battistuzzi L; Cusano R; Marzocchi C; Garrè ML; Clementi M; Scarrà GB
Am J Med Genet A; 2009 Jul; 149A(7):1539-43. PubMed ID: 19533801
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk and tumour spectrum in 172 patients with a germline
Guerrini-Rousseau L; Masliah-Planchon J; Waszak SM; Alhopuro P; Benusiglio PR; Bourdeaut F; Brecht IB; Del Baldo G; Dhanda SK; Garrè ML; Gidding CEM; Hirsch S; Hoarau P; Jorgensen M; Kratz C; Lafay-Cousin L; Mastronuzzi A; Pastorino L; Pfister SM; Schroeder C; Smith MJ; Vahteristo P; Vibert R; Vilain C; Waespe N; Winship IM; Evans DG; Brugieres L
J Med Genet; 2022 Jun; 59(11):1123-32. PubMed ID: 35768194
[TBL] [Abstract][Full Text] [Related]
13. Leiomyomatosis in an Infant With a SUFU Splice Site Variant: Case Report.
Rao RR; Dulken BW; Matalon DR; Borensztein M; McGuinness M; Cizek SM; Bruzoni M; Tan SY; Kreimer S
J Pediatr Hematol Oncol; 2022 Jul; 44(5):e914-e917. PubMed ID: 35398865
[TBL] [Abstract][Full Text] [Related]
14. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.
Cowan R; Hoban P; Kelsey A; Birch JM; Gattamaneni R; Evans DG
Br J Cancer; 1997; 76(2):141-5. PubMed ID: 9231911
[TBL] [Abstract][Full Text] [Related]
15. Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort.
Kloth K; Obrecht D; Sturm D; Pietsch T; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S
Front Oncol; 2021; 11():756025. PubMed ID: 34888241
[TBL] [Abstract][Full Text] [Related]
16. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.
Huq AJ; Walsh M; Rajagopalan B; Finlay M; Trainer AH; Bonnet F; Sevenet N; Winship IM
Fam Cancer; 2018 Oct; 17(4):601-606. PubMed ID: 29356994
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome.
Verkouteren BJ; Roemen GM; Schuurs-Hoeijmakers JH; Abdul Hamid M; van Geel M; Speel EM; Mosterd K
J Clin Pathol; 2023 May; 76(5):345-348. PubMed ID: 36002246
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161.
Smith MJ; Woodward ER; Evans DG
Fam Cancer; 2023 Jul; 22(3):341-344. PubMed ID: 36961676
[TBL] [Abstract][Full Text] [Related]
19. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]